MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy

被引：25
|
作者：
Umerez, Maitane [1 ]
Gutierrez-Camino, Angela [1 ]
Munoz-Maldonado, Carmen [1 ]
Martin-Guerrero, Idoia [1 ]
Garcia-Orad, Africa [1 ,2 ]
机构：
[1] Univ Basque Country, Fac Med & Nursery, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU,Barrio Sarriena S-N, Leioa, Spain
[2] BioCruces Hlth Res Inst, Baracaldo, Spain
来源：
PHARMACOGENOMICS & PERSONALIZED MEDICINE | 2017年 / 10卷
关键词：
MTHFR; methotrexate; toxicity; outcome; C677T; A1298C; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; GENETIC POLYMORPHISMS; TURKISH CHILDREN; CANDIDATE GENES; RISK-FACTORS; TOXICITY; PHARMACOGENETICS; ASSOCIATION; PREDICTION; PROGNOSIS;
D O I：
10.2147/PGPM.S107047
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Methotrexate (MTX) is an important component in the therapy used to treat childhood acute lymphoblastic leukemia ( ALL). Methylenetetrahydrofolate reductase ( MTHFR) is a key enzyme for MTX pharmacokinetics. Two single-nucleotide polymorphisms in MTHFR gene, C677T and A1298C, affecting MTHFR activity, have been widely studied as potential markers of MTX toxicity and/or outcome in pediatric ALL. In this review, we show that the majority of published reports do not find association or present opposite effect. Therefore, MTHFR C677T and A1298C polymorphisms do not seem to be good markers of MTX-related toxicity and/or outcome in pediatric ALL. The efforts should be focused on other genes, such as transporter genes or microRNA-related genes.
引用
收藏
页码：69 / 78
页数：10
相关论文
共 50 条
  • [21] RATIONAL USE OF METHOTREXATE IN MAINTENANCE THERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    WANG, ZH
    YU, ZL
    CHINESE MEDICAL JOURNAL, 1992, 105 (02) : 147 - 152
  • [22] INFLUENCE OF TRANSPORT PROTEIN GENE POLYMORPHISMS ON THE EFFECTS AND TOXICITY OF HIGH DOSE METHOTREXATE IN CHILDHOOD PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Lu, A.
    Zhang, L.
    Wang, B.
    Wu, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 55 - 55
  • [23] A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia
    Lopez-Lopez, E.
    Martin-Guerrero, I.
    Ballesteros, J.
    Garcia-Orad, A.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (06): : 498 - 506
  • [24] Influence of Dihydrofolate Reducatse (DHFR) Gene Polymorphisms on Outcome of Methotrexate Maintenance Therapy in Patients with Acute Lymphoblastic Leukemia
    Biswajit, Dubashi
    Kodidela, Sunitha
    Pradhan, Suresh Chandra
    Basu, Debdatta
    Prasad, Ravi
    Gurusamy, Umamaheswaran
    BLOOD, 2014, 124 (21)
  • [25] A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia
    E Lopez-Lopez
    I Martin-Guerrero
    J Ballesteros
    A Garcia-Orad
    The Pharmacogenomics Journal, 2013, 13 : 498 - 506
  • [26] MTHFR C677T polymorphisms and childhood acute lymphoblastic leukemia: A meta-analysis
    Wang, Jing
    Zhan, Ping
    Chen, Bing
    Zhou, Rongfu
    Yang, Yonggong
    Ouyang, Jian
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1596 - 1600
  • [27] Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia
    Matherly, LH
    Taub, JW
    LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) : 359 - 368
  • [28] Effect of MTHFR Polymorphisms on Methotrexate Efficacy in Acute Lymphocytic Leukemia Patient
    Mostafa-Hedeab, G.
    Ebid, G. T. A.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 8 - 9
  • [29] Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukeniia
    Krajinovic, M
    Lamothe, S
    Labuda, D
    Lemieux-Blanchard, ÉL
    Théorêt, Y
    Moghrabi, A
    Sinnett, D
    BLOOD, 2004, 103 (01) : 252 - 257
  • [30] MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy
    Frikha, Rim
    Elloumi, Moez
    Rebai, Tarek
    Kamoun, Hassen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (05) : 1031 - 1034
12345